ADVERTISEMENT

Edmonton

Rare one-time gene replacement therapy Zolgensma approved by Health Canada

Published

An Alberta boy, Kaysen Martin, underwent the Zolgensma gene-replacement therapy in December after an anonymous donor contributed $2 million to his family's fundraising campaign. At the time, the treatment made by Novartis was not approved by Health Canada. (Photo provided.)